Ares Commercial Real Estate Co. (NYSE:ACRE) announced a Not Available dividend on Wednesday, February 17th, Zacks reports. Shareholders of record on Wednesday, March 31st will be given a dividend of 0.35 per share by the real estate investment trust on Thursday, April 15th. The ex-dividend date of this dividend is Tuesday, March 30th.
Ares Commercial Real Estate has raised its dividend by 22.2% over the last three years and has increased its dividend annually for the last 1 consecutive years.
NYSE ACRE opened at $13.57 on Friday. The company has a quick ratio of 1.41, a current ratio of 1.41 and a debt-to-equity ratio of 2.98. The company has a market capitalization of $453.81 million, a P/E ratio of 26.10 and a beta of 1.33. Ares Commercial Real Estate has a 12-month low of $2.78 and a 12-month high of $17.72. The firm has a 50-day moving average price of $12.07 and a two-hundred day moving average price of $10.72.
Ares Commercial Real Estate (NYSE:ACRE) last issued its earnings results on Wednesday, February 17th. The real estate investment trust reported $0.41 EPS for the quarter, beating the consensus estimate of $0.35 by $0.06. Ares Commercial Real Estate had a net margin of 17.03% and a return on equity of 8.92%. Equities analysts expect that Ares Commercial Real Estate will post 1.27 EPS for the current year.
ACRE has been the subject of several analyst reports. Raymond James restated a "buy" rating and issued a $11.00 target price on shares of Ares Commercial Real Estate in a research report on Friday, December 4th. Zacks Investment Research cut shares of Ares Commercial Real Estate from a "buy" rating to a "hold" rating in a research report on Tuesday, December 29th. BTIG Research initiated coverage on shares of Ares Commercial Real Estate in a research report on Tuesday, February 2nd. They issued a "buy" rating and a $13.50 target price for the company. Finally, TheStreet upgraded shares of Ares Commercial Real Estate from a "d+" rating to a "c" rating in a research report on Wednesday, November 18th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Ares Commercial Real Estate has an average rating of "Buy" and an average target price of $11.64.
About Ares Commercial Real Estate
Ares Commercial Real Estate Corporation, a specialty finance company, originates and invests in commercial real estate (CRE) loans and related investments in the United States. It provides a range of financing solutions for the owners, operators, and sponsors of CRE properties. The company originates senior mortgage loans, subordinate debt products, real estate preferred equity investments, mezzanine loans, and other CRE investments, including commercial mortgage backed securities.
Read More: What is total return in investing?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
7 Marijuana Stocks Worth Speculating On
To say it’s been a rough two years for the cannabis industry is an understatement. Due to a combination of issues (including some self-inflicted wounds), the cannabis boom predicted in 2018 has not materialized. But that could be about to change.
If Joe Biden wins the presidential election, it will likely be part of a “Blue Wave” that will bring Democratic party control of both houses of Congress. And even if President Trump successfully wins a second term, it is still possible that Republicans could lose their hold on the Senate.
The bottom line is there is a range of outcomes that are possible. Most of those outcomes are favorable to the legalization of marijuana. And even if cannabis is not made legal on the federal level, it seems likely that the remaining states holding out will take steps to legalization. That’s because, like gambling, cannabis may create an economic lift that cash-strapped states may find too difficult to turn down.
One thing is certain. If you wait until the right time, you’ll have missed out on some eye-popping initial gains. But to get that reward in the future, you’ll need to assume some risk now. In this special presentation, we’ve identified seven cannabis stocks that you can consider when evaluating your opportunity in the cannabis sector.
View the "7 Marijuana Stocks Worth Speculating On ".